Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells

British Journal of Haematology

Volumn 102, Issue 3, 1998, Pages 759-767

  Traycoff, Christie M ^a,b   Halstead, Bartley ^a   Rice, Susan ^a   Mcmahel, Jon ^a   Srour, Edward F ^a,b   Cornetta, Kenneth ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell cycle; Chronic myelogenous leukaemia; Cytokines; Proliferation

Indexed keywords

CD34 ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD34; APOPTOSIS; BONE MARROW CELLS; CELL DIVISION; G0 PHASE; G1 PHASE; HUMANS; INTERLEUKIN-3; INTERLEUKIN-6; LEUKEMIA, MYELOID, CHRONIC-PHASE; MIDDLE AGED; STEM CELL FACTOR; TUMOR CELLS, CULTURED;

EID: 0031839844     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00839.x     Document Type: Article

References (38)

1. Agarwal, R., Doren, S., Hicks, B. & Dunbar, C.E. (1995) Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor-deficient stroma favors benign progenitors. Blood, 85, 1306-1312.
2. Amos, T., Lewis, J., Grand, F., Gooding, R., Goldman, J. & Gordon, M. (1995) Apoptosis in chronic myelogenous leukaemia: normal responses by progenitor cells to growth factor deprivation. X-irradiation and glucocorticoids. British Journal of Haematology, 91, 387-393.
3. Bedi, A., Zehnbauer, B.A., Barber, J.P. Sharkis, S.J. & Jones, R.J. (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 83, 2038-2044.
4. Ben-Neriah, Y., Daley, G., Mes-Masson, A.-M., Witte, O. & Baltimore, D. (1986) The chronic-myelogenous leukemia-specific P210 protein is the product of the bcr-abl hybrid gene. Science, 233, 212-214.
5. + Lin cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood, 77, 2316-2321.
6. Braun, S., McIvor, R., Davidson, A., Hanna, M., Traycoff, C., Berebetsky, D., Gonin, R., Broxmeyer, H. & Cornetta, K. (1997) Retrovirally mediated gene transfer of Arg22 and Try22 forms of dihydrofolate reductase into the hematopoietic cell line K562: a comparison of methotrexate resistance. Cancer Gene Therapy, 4, 26-32.
7. Cornetta, K., Moore, A., Leemhuis, T., Moen, R.C., Tricot, G., Leibowitz, D. & Hoffman, R. (1994) Retroviral mediated gene transfer in chronic myelogenous leukaemia. British Journal of Haematology, 87, 308-316.
8. Coulombel, L., Kalousek, D., Eaves, C., Gupta, C. & Eaves, A. (1983) Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. New England Journal of Medicine, 308, 1493-1498.
9. Daley, G.Q., VanEtten, R.A. & Baltimore, D (1990) Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-830.
10. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P. & Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808.
11. Dormer, P., Lau, B. & Wilmanns, W. (1980) Kinetics of bone marrow cell production in human acute and chronic myeloid leukemias. Leukemia Research, 4, 231-237.
12. Eaves, A.C., Cashman, J.D., Gaboury, L.A., Kalousek, D.K. & Eaves, C.J. (1986) Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proceedings of the National Academy of Sciences of the United States of America, 83, 5306-5310.
13. Emanuel, P., Bates, L., Castleberry, R., Gualtieri, R. & Zuckerman, K. (1991) Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood, 77, 925-929.
14. Fialkow, P.J., Gartler, S.M. & Yoshida, A. (1967) Clonal origin of chronic myelocytic leukemia in man. Proceedings of the National Academy of Sciences of the United States of America, 58, 1468-1471.
15. Goldman, J.M. & Lu, D.P. (1982) New approaches in chronic granulocytic leukemia: origin, prognosis, and treatment. Seminars in Hematology, 19, 241-256.
16. Groffen, J., Stephenson, J., Heisterkamp, N., de Klein, A., Bartram, C. & Grosveld, G. (1984) Philadelphia chromosomal breakpoints are clustered within a limited region, bcr. on chromosome 22. Cell, 36, 93-99.
17. Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pattengale, P. & Jones, G. (1990) Acute leukemia in bcr/abl transgenic mice. Nature, 344, 251-253.
18. Issaad, C. & Vainchenker, W. (1994) Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor. Blood, 84, 3447-3456.
19. 0. Blood, 90, 658-668.
20. Leemhuis, T., Leibowitz, D., Cox, G., Srour, E.F., Tricot, G. & Hoffman, R. (1992) Selection of BCR/ABL-negative progenitor cells from chronic myeloid leukemia marrow. Progress in Clinical and Biological Research, 377, 231-237.
21. Lepine, J. & Messner, H. (1983) Pluripotent hemopoietic progenitors (CFU-GEMM) in chronic myelogenous leukemia. International Journal of Cell Cloning, 1, 230-239.
22. McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K.M., Green, D.R. & Cotter, T.G. (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83, 1179-1187.
23. McGlave, P. (1990) Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival. Seminars in Hematology, 27, 23-30.
24. Miller, D.G., Mohammed, A.D. & Miller, A.D. (1990) Gene transfer by retrovirus vector occurs only in cells that are actively replicating at the time of infection. Molecular and Cellular Biology 10, 4239-4242.
25. Nolta, J.A. & Kohn, D.B. (1990) Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Human Gene Therapy, 1, 257-268.
26. Rowley, J. (1973) A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243, 290-293.
27. Rowley, P., Keng, P. & Kosciolek, B. (1996) The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells. Leukemia Research, 20, 473-480.
28. Shtivelman, E., Lifshitz, B., Gale, R. & Canaani, E. (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature, 315, 550-554.
29. Smetsers, T.F., Skorski, T., van de Locht, L.T., Wessels, H.M., Pennings, A.H., de Witte, T., Calabretta, B. & Mensink, E.J. (1994) Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173. Leukemia, 8, 129-140.
30. - bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells, 17, 287-295.
31. Srour, E.F., Zanjani, E.D., Cornetta, K., Traycoff, C.M., Flake, A.W., Hedrick, M., Brandt, J.E., Leemhuis, T. & Hoffman, R. (1993) Persistence of human multilineage, self-renewing lymphohema-topoietic stem cells in chimeric sheep. Blood, 82, 3333-3342.
32. Szczylik, C., Skorski, T., Nicolaides, N., Manzella, L., Malaguarnera, L., Venturelli, D., Gerwirtz, A. & Calabretta, B. (1991) Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynudeotides. Science, 253, 562-565.
33. Traycoff, C.M., Abboud, M.R., Laver, J., Brandt, J.E., Hoffman, R., Law, P., Ishizawa, L. & Srour, E.F. (1994a) Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Experimental Hematology, 22, 215-222.
34. + cells an enhanced ex vivo expansion potential. Experimental Hematology, 22, 1264-1272.
35. Traycoff, C., Srour, E., Dutt, P., Fan, Y. & Cornetta, K. (1997) The 30/ 35 kDa chymotryptic fragment of fibronectin enhances retroviral-mediated gene transfer in purified chronic myelogenous leukemia bone marrow progenitors. Leukemia, 11, 159-167.
36. + cells. Bone Marrow Transplantation, 19, 1213-1221.
37. Verfaillie, C., Blakolmer, K. & McGlave, P. (1990) Purified primitive human hematopoietic progenitor cells with long term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma. Journal of Experimental Medicine, 172, 509-512.
38. Verfaillie, C.M., Miller, W.J., Boylan, K. & McGlave, P.B. (1992) Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood, 79, 1003-1010.